Lupin set for first launch in US generic oral contraceptive market
This article was originally published in Scrip
Executive Summary
Lupin has announced its foray into the US generic oral contraceptives market, with its first product, norethindrone tablets 0.35mg, receiving final FDA approval. The Indian firm said that it expects to commence shipping the progestin-only pill shortly.